Northern Trust Corp Fulgent Genetics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 213,071 shares of FLGT stock, worth $3.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

213,071

Previous 217,531 2.05%

Holding current value

$3.92 Million

Previous $4.27 Million 8.44%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$19.6 - $25.06 $87,416 - $111,767	-4,460 Reduced 2.05%	213,071 $4.63 Million
Q2 2024 Aug 14, 2024	SELL	$19.09 - $22.57 $66,757 - $78,927	-3,497 Reduced 1.58%	217,531 $4.27 Million
Q1 2024 May 14, 2024	SELL	$21.55 - $29.29 $223,430 - $303,678	-10,368 Reduced 4.48%	221,028 $4.8 Million
Q4 2023 Feb 13, 2024	BUY	$23.64 - $30.27 $179,380 - $229,688	7,588 Added 3.39%	231,396 $6.69 Million
Q3 2023 Nov 13, 2023	BUY	$26.74 - $40.81 $12,460 - $19,017	466 Added 0.21%	223,808 $5.98 Million
Q2 2023 Aug 11, 2023	SELL	$28.52 - $40.7 $37,703 - $53,805	-1,322 Reduced 0.59%	223,342 $8.27 Million
Q1 2023 May 15, 2023	SELL	$29.39 - $36.27 $37,060 - $45,736	-1,261 Reduced 0.56%	224,664 $7.01 Million
Q4 2022 Feb 13, 2023	BUY	$29.23 - $40.28 $165,324 - $227,823	5,656 Added 2.57%	225,925 $6.73 Million
Q3 2022 Nov 14, 2022	SELL	$37.92 - $63.74 $1.45 Million - $2.44 Million	-38,244 Reduced 14.79%	220,269 $8.4 Million
Q2 2022 Aug 12, 2022	BUY	$47.98 - $62.75 $1.86 Million - $2.44 Million	38,851 Added 17.69%	258,513 $14.1 Million
Q1 2022 May 13, 2022	SELL	$49.85 - $96.11 $2.04 Million - $3.93 Million	-40,926 Reduced 15.71%	219,662 $13.7 Million
Q4 2021 Feb 08, 2022	BUY	$77.3 - $105.0 $87,658 - $119,070	1,134 Added 0.44%	260,588 $26.2 Million
Q3 2021 Nov 15, 2021	BUY	$74.87 - $110.87 $7.59 Million - $11.2 Million	101,391 Added 64.15%	259,454 $23.3 Million
Q2 2021 Aug 13, 2021	SELL	$66.8 - $100.45 $1.88 Million - $2.83 Million	-28,199 Reduced 15.14%	158,063 $14.6 Million
Q1 2021 May 12, 2021	BUY	$59.3 - $183.85 $68,965 - $213,817	1,163 Added 0.63%	186,262 $18 Million
Q4 2020 Feb 11, 2021	BUY	$31.01 - $52.1 $1.1 Million - $1.84 Million	35,402 Added 23.65%	185,099 $9.64 Million
Q3 2020 Nov 16, 2020	SELL	$15.89 - $50.51 $32,415 - $103,040	-2,040 Reduced 1.34%	149,697 $5.99 Million
Q2 2020 Aug 14, 2020	BUY	$8.89 - $18.28 $1.1 Million - $2.25 Million	123,253 Added 432.71%	151,737 $2.43 Million
Q1 2020 May 14, 2020	SELL	$6.75 - $19.75 $175 - $513	-26 Reduced 0.09%	28,484 $306,000
Q4 2019 Feb 14, 2020	BUY	$9.29 - $15.82 $104,856 - $178,560	11,287 Added 65.53%	28,510 $368,000
Q3 2019 Nov 13, 2019	BUY	$5.96 - $12.81 $102,649 - $220,626	17,223 New	17,223 $179,000

Others Institutions Holding FLGT

# of Institutions

200

Shares Held

16M

Call Options Held

2.04M

Put Options Held

14K

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $557M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Fulgent Genetics, Inc. Transaction History